The Applicability of Comorbidity Indices in Predicting Chemo toxicity in Non-Small Cell Lung Cancer

被引：1
作者：
Edahyr, Boshra [1 ]
Lind, Michael [2 ]
Karsera, Louise [1 ]
Mafi, Reza [1 ]
Wallace, Karen [1 ]
Howell, Gareth [1 ]
Hemmingway, Carl [1 ]
Stubbs, Karen [1 ]
机构：
[1] Univ Hull, Acad Oncol, Cottingham, England
[2] Univ Hull, Hull York Med Sch, Cottingham, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Co-morbidity; toxicity; predictive;
D O I：
10.1016/j.jtho.2016.11.2038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PUB068
引用
收藏
页码：S1487 / S1488
页数：2
相关论文
共 50 条
  • [31] Re-Irradiation of Recurrent Non-Small Cell Lung Cancer
    Hunter, Benjamin
    Crockett, Cathryn
    Faivre-Finn, Corrinne
    Hiley, Crispin
    Salem, Ahmed
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2021, 31 (02) : 124 - 132
  • [32] Chemotherapy in elderly patients with advanced non-small cell lung cancer
    Quoix, Elisabeth
    Westeel, Virginie
    Zalcman, Gerard
    Milleron, Bernard
    [J]. LUNG CANCER, 2011, 74 (03) : 364 - 368
  • [33] Gemcitabine and carboplatin: is this the best combination for non-small cell lung cancer?
    Saha, Antonio
    Rudd, Robin
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (02) : 165 - 173
  • [34] The safety and efficacy of pembrolizumab for the treatment of non-small cell lung cancer
    Mazarico Gallego, Jose Ma
    Herrera Juarez, Mercedes
    Paz-Ares, Luis
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (03) : 233 - 242
  • [35] Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer Patients
    Nardone, Valerio
    Reginelli, Alfonso
    De Marco, Giuseppina
    Natale, Giovanni
    Patane, Vittorio
    De Chiara, Marco
    Buono, Mauro
    Russo, Gaetano Maria
    Monti, Riccardo
    Balestrucci, Giovanni
    Salvarezza, Maria
    Di Guida, Gaetano
    D'Ippolito, Emma
    Sangiovanni, Angelo
    Grassi, Roberta
    D'Onofrio, Ida
    Belfiore, Maria Paola
    Cimmino, Giovanni
    Della Corte, Carminia Maria
    Vicidomini, Giovanni
    Fiorelli, Alfonso
    Gambardella, Antonio
    Morgillo, Floriana
    Cappabianca, Salvatore
    [J]. DIAGNOSTICS, 2023, 13 (03)
  • [36] Update on the role of topotecan in the treatment of non-small cell lung cancer
    Stewart, DJ
    [J]. ONCOLOGIST, 2004, 9 : 43 - 52
  • [37] Stage III Non-small Cell Lung Cancer Management in England
    Adizie, J. B.
    Khakwani, A.
    Beckett, P.
    Navani, N.
    West, D.
    Woolhouse, I
    Harden, S., V
    [J]. CLINICAL ONCOLOGY, 2019, 31 (10) : 688 - 696
  • [38] Impact of Interstitial Lung Disease on Survival for Patients with Non-small Cell Lung Cancer
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Kurishima, Koichi
    Nakamura, Ryota
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Ohara, Gen
    Hizawa, Nobuyuki
    [J]. ANTICANCER RESEARCH, 2009, 29 (07) : 2671 - 2674
  • [39] Predictors of Immunotherapy Efficacy in Metastatic Non-Small Cell Lung Cancer: Lung Immune Prognostic Index and Immune-Related Toxicity
    Pellitero, Alba Moratiel
    Garcia, Maria Zapata
    Ruiz, Marta Gascon
    Arbones-Mainar, Jose Miguel
    Prado, Rodrigo Lastra del
    Isla, Dolores
    [J]. WORLD JOURNAL OF ONCOLOGY, 2024, 15 (02) : 223 - 238
  • [40] Validation of RTOG 0813 Normal Tissue Constraints for Pulmonary Toxicity in SBRT for Central Non-Small Cell Lung Cancer
    Verdecchia, K.
    Manyam, B.
    Videtic, G.
    Zhuang, T.
    Woody, N.
    Stephans, K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S356 - S356
12345